Biotech

All Articles

Repare lays off 25% of team as biotech stops preclinical R&ampD

.Repare Therapy is giving up a fourth of its staff as the oncology biotech downsize its own preclini...

J &amp J files for FDA permission of $6.5 B autoimmune medication

.Johnson &amp Johnson has actually taken another measure towards understanding a yield on its $6.5 b...

Gain's stage 1 gain paves method to prove Parkinson's medication's worth

.Increase Rehabs has set its own sights on confirming the effectiveness of its Parkinson's health co...

Actinogen files brand-new period 2 data to recover clinical depression drug

.Actinogen Medical's hopes-- as well as sell rate-- have actually rebounded a little coming from ear...

Pfizer and also Flagship incorporate Ratio to multibillion-dollar equation

.Flagship Pioneering and also Pfizer have included Quotient in to their 10-program collaboration, in...

Bayer markers $547M contract to drive boundaries of noncoding RNA

.Bayer execs were actually interested to stress and anxiety to Strong this summer season that the Ge...

UK reveals programs to introduce 18 brand-new scientific test hubs

.Surrounded by a yearslong medical test downtrend in the U.K., a brand-new public-private relationsh...

UPDATE: Genentech telegrams 93 layoffs in The golden state after discussing programs to shutter cancer immunology research study device

.Observing the news of a large cutback shot in April as well as a significant rebuilding initiative ...

Neurocrine's KarXT opponent reaches in period 2-- but simply at low dose

.Neurocrine Biosciences has achieved its own hoped-for profile page in a period 2 schizophrenia test...

Vaderis' uncommon capillary condition medicine minimizes nosebleeds

.Vaderis Therapeutics' target to establish the very first medicine targeted particularly at a partic...